Latest Healthcare in India Stories
SAN DIEGO, July 26, 2012 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, today announced that it will release its second quarter ended June 30, 2012 financial results on Thursday, August 2, 2012. Cadence management will host a conference call and live webcast to discuss the financial results on Thursday, August...
SINGAPORE, July 26, 2012 /PRNewswire/ -- The healthcare industry in Asia Pacific (APAC) is rapidly growing, fuelled by increased spending on health, liberalization of investment policies, growing medical tourism activity, and high adoption of new technologies. Accounting for more than 60 per cent of the world's total population, the region presents significant growth opportunities to meet the growing needs of a rapidly growing and ageing population. In 2011, the APAC healthcare...
MUMBAI, India, July 11, 2012 /PRNewswire/ -- 21-23 August, The Lalit Mumbai, India CPhI Conferences brings to you for the first time in India, a two-day strategic conference, Pharma Extractables and Leachables 2012, taking place from 22-23 August in Mumbai, India. The event also includes an exclusive seminar on overcoming E&L challenges in formulations, taking place on 21 August. This highly technical event has received a lot of interest and has already...
SAN DIEGO, July 9, 2012 /PRNewswire/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the Company's Chief Executive Officer, Brian M. Culley, will present at the OneMedForum New York 2012 Emerging Company Finance Conference on Thursday, July 12, 2012 at 9:45 a.m. Eastern time, at the Metropolitan Club in New York City. (Logo: http://photos.prnewswire.com/prnh/20120612/LA22456LOGO-a) Interested parties can access a live audio webcast and slide presentation on...
POINT RICHMOND, Calif., July 5, 2012 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, announced today that Transcept management is scheduled to present at the JMP Securities Healthcare Conference in New York on July 12, 2012 at 4:00 p.m. ET. A live audio webcast and replay of this...
CALGARY, June 18, 2012 /PRNewswire/ - Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC, NASDAQ:ONCY), will present a corporate overview of the Company at the Bloom Burton & Co. Healthcare Investor Conference on June 21(st), 2012 at 10:30 am ET. The Conference is being held at the Toronto Board of Trade, 1 First Canadian Place, Toronto, Ontario on June 21(st) between 8:30 am and 4:30 pm ET. The Bloom Burton & Co. Healthcare Investor Conference...
PARSIPPANY, N.J., June 15, 2012 /PRNewswire/ -- Pharmaceutical and biotechnology major Wockhardt announced that its US subsidiary, Wockhardt USA LLC was honoured with the presentation of the 2012 DIANA Award by the Healthcare Distribution Management Association (HDMA) for the 'Best Overall Generic Product Manufacturer' with sales of up to USD 100 million in the healthcare distributor market at their prestigious annual Business & Leadership Conference in San Antonio,...
CALGARY, June 15, 2012 /PRNewswire/ - Oncolytics Biotech Inc. (TSX: ONC) (NASDAQ: ONCY) announced today that its 2012 Annual and Special Meeting of Shareholders will be held on Wednesday, June 20, 2012 at 4:30 p.m. ET at the Hilton Toronto Hotel, 145 Richmond Street West, Toronto, Ontario. Following the business portion of the meeting, Dr. Brad Thompson, President and CEO of Oncolytics, will discuss recent progress in the development of REOLYSIN(®) as a potential cancer...
POINT RICHMOND, Calif., June 4, 2012 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, announced today that John A. Kollins will join the Company, effective June 1, 2012, and serve as Senior Vice President and Chief Business Officer. In this new position, Mr. Kollins will have primary...
POINT RICHMOND, Calif., June 1, 2012 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, announced today that Transcept management is scheduled to present at the Jefferies 2012 Global Healthcare Conference in New York on June 7, 2012 at 1:30 p.m. ET. A live audio webcast and replay of this...
